# Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/incidence-of-programmed-cell-death-1-inhibitor-related-pneumonitis-in-patients/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Mizuki Nishino,Anita Giobbie‐Hurder,Hiroto Hatabu,Nikhil H. Ramaiya,F. Stephen Hodi |
| Citations | 762 |
| DOI | 10.1001/jamaoncol.2016.2453 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://jamanetwork.com/journals/jamaoncology/articlepdf/2544610/coi160041.pdf |
| OpenAlex ID | https://openalex.org/W2508205285 |
| PMID | 27540850 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Mizuki Nishino](https://scholariq.org/researchers/mizuki-nishino/)

## Paper journal

- [JAMA Oncology](https://scholariq.org/journals/jama-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.